Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6165)
All Articles published online
|
Publishing Process of This Article
|
Mar 28, 2014 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Germano D, Daniele B. Systemic therapy of hepatocellular carcinoma: Current status and future perspectives. World J Gastroenterol 2014; 20(12): 3087-3099 [PMID: 24696596 DOI: 10.3748/wjg.v20.i12.3087] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i12/3087.htm |
| Number | Citing Articles |
| 1 |
GANG HUANG, LIMEI LI, WEIPING ZHOU. USP14 activation promotes tumor progression in hepatocellular carcinoma. Oncology Reports 2015; 34(6): 2917 doi: 10.3892/or.2015.4296
|
| 2 |
Junying Wang, Daniel J. McGrail, Parnit K. Bhupal, Wen Zhang, Kuan-Yu Lin, Yi-Hsuan Ku, Tao Lin, Hongfu Wu, Kyle C. Tsai, Kaiyi Li, Cheng-Yuan Peng, Milton J. Finegold, Shiaw-Yih Lin, Robert Y.L. Tsai. Nucleostemin Modulates Outcomes of Hepatocellular Carcinoma via a Tumor Adaptive Mechanism to Genomic Stress. Molecular Cancer Research 2020; 18(5): 723 doi: 10.1158/1541-7786.MCR-19-0777
|
| 3 |
Gayatri Gouda, Manoj Kumar Gupta, Ravindra Donde, Lambodar Behera, Ramakrishna Vadde. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 109 doi: 10.1016/B978-0-323-98806-3.00007-6
|
| 4 |
Lei-Bo Xu, Chao Liu. Role of liver stem cells in hepatocarcinogenesis. World Journal of Stem Cells 2014; 6(5): 579-590 doi: 10.4252/wjsc.v6.i5.579
|
| 5 |
Xiangdan Cui, Aijun Zhang, Jianwei Liu, Kangkang Wu, Zhengfeng Chen, Qing Wang. Down-regulation of MAP2K1 by miR-539 inhibits hepatocarcinoma progression. Biochemical and Biophysical Research Communications 2018; 504(4): 784 doi: 10.1016/j.bbrc.2018.08.076
|
| 6 |
Jianting Long, Chunlin Jiang, Baoxian Liu, Shi Fang, Ming Kuang. MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF. Tumor Biology 2016; 37(5): 5821 doi: 10.1007/s13277-015-4427-6
|
| 7 |
Abdel Hady A. Abdel Wahab, Medhat S. El-Halawany, Ahmad A. Emam, Ammar Elfiky, Zakaria Y. Abd Elmageed. Identification of circulating protein biomarkers in patients with hepatocellular carcinoma concomitantly infected with chronic hepatitis C virus. Biomarkers 2016; : 1 doi: 10.1080/1354750X.2016.1252966
|
| 8 |
Javier Tejeda-Maldonado, Ignacio García-Juárez, Jonathan Aguirre-Valadez, Adrián González-Aguirre, Mario Vilatobá-Chapa, Alejandra Armengol-Alonso, Francisco Escobar-Penagos, Aldo Torre, Juan Francisco Sánchez-Ávila, Diego Luis Carrillo-Pérez. Diagnosis and treatment of hepatocellular carcinoma: An update. World Journal of Hepatology 2015; 7(3): 362-376 doi: 10.4254/wjh.v7.i3.362
|
| 9 |
Femke Heindryckx, Pär Gerwins. Targeting the tumor stroma in hepatocellular carcinoma. World Journal of Hepatology 2015; 7(2): 165-176 doi: 10.4254/wjh.v7.i2.165
|
| 10 |
Min‐Seok Park, Nan‐Hee Kim, Chang‐Won Kang, Chul‐Woong Oh, Gun‐Do Kim. Antimetastatic Effects of Gambogic Acid are Mediated via the Actin Cytoskeleton and NF‐κB Pathways in SK‐HEP1 Cells. Drug Development Research 2015; 76(3): 132 doi: 10.1002/ddr.21249
|
| 11 |
Iu. S. Taskaeva, N. P. Bgatova, A. O. Solovieva. Autophagy in Hepatocellular Carcinoma-29 after Single or Combined Administration of Lithium Carbonate and Rapamycin. Cell and Tissue Biology 2019; 13(5): 353 doi: 10.1134/S1990519X19050079
|
| 12 |
Sebastian Lünse, Claus-Dieter Heidecke, Lars Ivo Partecke. Hepatocellular Carcinoma. 2019; : 111 doi: 10.15586/hepatocellularcarcinoma.2019.ch6
|
| 13 |
Samantha Armstrong, Tina Roy, Bhavana Singh, Monika Kulasekaran, Fatima Shaukat, Xue Geng, Hongkun Wang, Petra Prins, Reena C. Jha, Marion L. Hartley, Aiwu Ruth He. TKIs beyond immunotherapy predict improved survival in advanced HCC. Journal of Cancer Research and Clinical Oncology 2023; 149(6): 2559 doi: 10.1007/s00432-022-04115-w
|
| 14 |
Senem Demir, Cigdem Özen, Meltem Ceylan‐Ünlüsoy, Mehmet Öztürk, Oya Bozdağ‐Dündar. Novel Furochromone Derivatives: Synthesis and Anticancer Activity Studies. Journal of Heterocyclic Chemistry 2019; 56(4): 1341 doi: 10.1002/jhet.3508
|
| 15 |
Ji-sheng Jing, Hongbo Li, Shun-cai Wang, Jiu-ming Ma, La-qing Yu, Hua Zhou. NDRG3 overexpression is associated with a poor prognosis in patients with hepatocellular carcinoma. Bioscience Reports 2018; 38(6) doi: 10.1042/BSR20180907
|
| 16 |
LEI ZHANG, YI LI, LIANG QIAO, YONGXUN ZHAO, YUCAI WEI, YUMIN LI. Protective effects of hepatic stellate cells against cisplatin-induced apoptosis in human hepatoma G2 cells. International Journal of Oncology 2015; 47(2): 632 doi: 10.3892/ijo.2015.3024
|
| 17 |
James Ronald, Andrew B. Nixon, Daniele Marin, Rajan T. Gupta, Gemini Janas, Willa Chen, Paul V. Suhocki, Waleska Pabon-Ramos, David R. Sopko, Mark D. Starr, John C. Brady, Herbert I. Hurwitz, Charles Y. Kim. Pilot Evaluation of Angiogenesis Signaling Factor Response after Transcatheter Arterial Embolization for Hepatocellular Carcinoma. Radiology 2017; 285(1): 311 doi: 10.1148/radiol.2017162555
|
| 18 |
G.J. Wengert, H. Bickel, J. Breitenseher, A. Ba-Ssalamah. Primäre Lebertumoren. Der Radiologe 2015; 55(1): 27 doi: 10.1007/s00117-014-2705-8
|
| 19 |
Lili Cao, Lijun Zhang, Xiang Zhao, Ye Zhang, Daolin Tang. A Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma Cells. PLOS ONE 2016; 11(8): e0161025 doi: 10.1371/journal.pone.0161025
|
| 20 |
Bader Abdelmaksoud. Safety and Efficacy of Continuous Low-dose Doxorubicin and Fluorouracil (5FU) with Best Supportive Care Compared to Best Standard of Care alone for Patients with Advanced Hepatocellular Carcinoma. International Journal of Cancer and Oncology 2017; 4(1): 1 doi: 10.15436/2377-0902.16.1194
|
| 21 |
Lorena Rico, Michael E. Østergaard, Melanie Bell, Punit P. Seth, Stephen Hanessian. Studies directed toward the asialoglycoprotein receptor mediated delivery of 5-fluoro-2′-deoxyuridine for hepatocellular carcinoma. Bioorganic & Medicinal Chemistry Letters 2018; 28(15): 2652 doi: 10.1016/j.bmcl.2018.06.002
|
| 22 |
Mahmoud M. Kamel, Mohamed F. Saad, Amal A. Mahmoud, Awatief A. Edries, Ahmed S. Abdel-Moneim. Evaluation of serum PIVKA-II and MIF as diagnostic markers for HCV/HBV induced hepatocellular carcinoma. Microbial Pathogenesis 2014; 77: 31 doi: 10.1016/j.micpath.2014.10.009
|
| 23 |
Xuefeng Gu, Hongbo Li, Ling Sha, Wei Zhao. A prognostic model composed of four long noncoding RNAs predicts the overall survival of Asian patients with hepatocellular carcinoma. Cancer Medicine 2020; 9(16): 5719 doi: 10.1002/cam4.3275
|
| 24 |
Quanwu Su, Hongxia Wang. Long non-coding RNA 01559 mediates the malignant phenotypes of hepatocellular carcinoma cells through targeting miR-511. Clinics and Research in Hepatology and Gastroenterology 2021; 45(2): 101648 doi: 10.1016/j.clinre.2021.101648
|
| 25 |
Cigdem Ozen, Meltem Ceylan-Unlusoy, Mehmet Ozturk, Oya Bozdag-Dundar. A novel chromonyl thiohydantoin with anti-proliferative action on primary hepatocellular carcinoma cells. Medicinal Chemistry Research 2018; 27(1): 153 doi: 10.1007/s00044-017-2037-0
|
| 26 |
Yannan Zheng, Wenhui Zhang, Lin Xu, Hua Zhou, Man Yuan, Hongxi Xu. Recent Progress in Understanding the Action of Natural Compounds at Novel Therapeutic Drug Targets for the Treatment of Liver Cancer. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.795548
|
| 27 |
Jan Erik Slotta, Otto Kollmar, Volker Ellenrieder, B Michael Ghadimi, Kia Homayounfar. Hepatocellular carcinoma: Surgeon's view on latest findings and future perspectives. World Journal of Hepatology 2015; 7(9): 1168-1183 doi: 10.4254/wjh.v7.i9.1168
|
| 28 |
Xiaoyun Dai, Kwang Seok Ahn, Ling Zhi Wang, Chulwon Kim, Amudha Deivasigamni, Frank Arfuso, Jae-Young Um, Alan Prem Kumar, Young-Chae Chang, Dhiraj Kumar, Gopal C. Kundu, Junji Magae, Boon Cher Goh, Kam Man Hui, Gautam Sethi. Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma. Molecular Cancer Therapeutics 2016; 15(12): 2966 doi: 10.1158/1535-7163.MCT-16-0391
|
| 29 |
Yuwen Wang, Shujun Zhang, Jia Liu, Biaobiao Fang, Jie Yao, Binglin Cheng. Matrine inhibits the invasive and migratory properties of human hepatocellular carcinoma by regulating epithelial‑mesenchymal transition. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9023
|
| 30 |
Youmei Peng, Wenquan Yu, Ertong Li, Jinfeng Kang, Yafeng Wang, Qinghua Yang, Bingjie Liu, Jingmin Zhang, Longyu Li, Jie Wu, Jinhua Jiang, Qingduan Wang, Junbiao Chang. Discovery of an Orally Active and Liver-Targeted Prodrug of 5-Fluoro-2′-Deoxyuridine for the Treatment of Hepatocellular Carcinoma. Journal of Medicinal Chemistry 2016; 59(8): 3661 doi: 10.1021/acs.jmedchem.5b01807
|
| 31 |
Medhat S. El-Halawany, Heba M. Ismail, Ahmed A. Zeeneldin, Ammar Elfiky, Marwa Tantawy, Mohamed H. Kobaisi, Ikram Hamed, Abdel Hady A. Abdel Wahab. Investigating the Pretreatment miRNA Expression Patterns of Advanced Hepatocellular Carcinoma Patients in Association with Response to TACE Treatment. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/649750
|
| 32 |
Siqi Liao, Qingliang Wang, Siyuan Chen, Qixuan Huang, Li Zhou, Hongtao Liu, Song He, Zhihang Zhou. Mito-LND and (E)-Akt inhibitor-IV: novel compounds inducing endoplasmic reticulum stress and ROS accumulation against hepatocellular carcinoma. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05545-5
|
| 33 |
Peng Zhao, Li Chen, Lin-Hu Li, Zhi-Feng Wei, Bei Tong, Yu-Gai Jia, Ling-Yi Kong, Yu-Feng Xia, Yue Dai. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-987
|